Recent Updates
Recently added Catalysts
TNGX Positive Sentiment Score: 70/100

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

Wednesday, December 17, 2025 1 min read
Key Takeaway: Tango Therapeutics, Inc. (NASDAQ: TNGX) announced its participation in the upcoming 44th Annual J.P. Morgan Healthcare Conference where CEO Dr. Barbara Weber will present. The event is scheduled for January 14, 2026, at 9:45 am PST/12:45 pm EST. The presentation will be accessible via a live webcast and will be archived for 90 days on the company’s website, which enhances investor engagement opportunities. Tango Therapeutics focuses on developing precision medicine for cancer treatment leveraging synthetic lethality.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tango Therapeutics is participating in a prestigious healthcare conference.
  • CEO Barbara Weber will present, highlighting leadership visibility.
  • Live webcast and archive offer accessibility to potential investors.

Full Press Release Details

BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST/12:45pm EST.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:

Frequently Asked Questions

When will Tango Therapeutics present at the J.P. Morgan Healthcare Conference?

Tango Therapeutics will present on January 14, 2026, at 9:45am PST.

Where can I find the live webcast of the presentation?

The live webcast will be available on the Company's 'Investors' page.

How long will the webcast replay be available?

The webcast replay will be archived for 90 days after the presentation.

What is the focus of Tango Therapeutics?

Tango Therapeutics focuses on developing precision medicine for cancer treatment.

What principle does Tango Therapeutics use for therapy development?

Tango utilizes the genetic principle of synthetic lethality in their therapy development.

Tags: TNGX Viatris Investor Conferences Healthcare J.P. Morgan Healthcare Conference Barbara Weber precision medicine cancer treatment
Last updated: Dec 17, 2025